Zusammenfassung
Histopathologisch ist die Abgrezung eines Nebennierenrindentumors von einem Phäochromozytom am ehesten durch den Nachweis einer negativen Chromogranin A-Färbung möglich.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Clemmesen J (1965) Statistical studies in the aetiology of malignant neoplasma. II Munksgaard, Copenhagen. Danish Cancer Registry under National Anti-Cancer League
Bradley L III (1975) Primary and adjunctive therapy in carcinoma of the adrenal cortex. Surg Gynecol Obstet 141: 507
Luton JP, Cerdas S, Billaud L et al. (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy 322 (17): 195 —1201
Yano T, Linehan M, Anglard T et al. (1989) Genetic changes in human adrenocortical carcinomas. J N C I 81 (7): 518–523
Cibas E, Medeiros J, Weinberg D et al. (1990) Cellular DNA Profiles of Benign and Malignant Adrenocortical Tumors 14 (10) :948–955
Macfarlane D (1958) Cancer of the adrenal cortex. The natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 23: 155–185
Gröndal S, Eriksson B, Hagenäs L et al. (1990) Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endorinol (Copenh) 122: 656–663
Bodie B, Novick A, Pontes E et al. (1989) The Cleveland Clinic experience with adrenal cortical carcinoma. J of Urol 141: 257–260
Thompson NW (1983) Adrenocortical carcinomas. In: Thompson NW, Vinik AI, (eds) Endocrine Surgery Update, Grane and Stratton, New York
Schteingardt DE, Motazedi A, Noonan RA, Thompson NW (1982) Treatment of adrenal carcinomas. Arch Surg 117: 1142–1146
Lubitz JA, Freeman L, Okun R. Mitotane ause in inoperable adrenal cortical carcinoma. JAMA 223: 1109–1112
Eriksson B, Öberg K, Curstedt T et al. (1987) Treatment of hormone-producing adrenocortical cancer with o.p’DDD and streptozocin 59 (8): 1398–1403
Flack MR, Pyle RG, Mullen NM et al. (1993) Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab 76: 1019–1024
Stein LA, La Rocca R, Thomas R et al. (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncology 7 (4): 499–508
van Slooten H, Moolenar AJ, van Seters AP, Smeenk F (1984) The treatment of adrenocortical carcinoma with o.p’DDD: prognostic simplications of serum level monitoring Eur J Cancer Clin Oncol 20 (11): 47–53
Tattersall MHN, Lander H, Bain B et al. (1980) Cis-platinum treatment of metastatic adrenal carcinoma. Med J Aust 1: 419–421
Haq M, Legha S, Samaan N et al. (1980) Cytotoxic chemotherapy in adrenal cortical carcinoma. Cancer Treat Rep 64: 909–913
van Slooten H, van Oosterom AT (1983) CAP (Cyclophosphamide, Doxorubicin and Cisplatin) Regimen in Adrenal Cortical Carcinoma. Cancer Treat Rep 67 (4): 377–379
Johnson D, Greco A (1986) Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16) Cancer 58: 2198–2202
Crocket P, Clark ACL (1989) Combination chemotherapy for adrenal carcinoma: response in a 51/2-year-old male. Medical and Pediatric Oncology 17: 62–65
Schlumberger M, Brugierers L, Gicquel C et al. (1991) 5-Fluorouracil, doxorubine and cisplatin as treatment for adrenal cortical carcinoma. Cancer 67: 2997–3000
Page DL, DeLellis RA, Hough AJ (1986) Tumors of the adrenal. In: Atlas of Tumor Pathology, Washington DC, AFIP
Manager WM, Gifford RW Jr, Hoffman BB (1985) Pheochromocytoma a clinical and experimental overview. Curr Probl Cancer 9: 1
Irvin GL, Fishman LM, Sher JA (1983) Familial pheochromocytoma. Surgery 94: 938
Cryer PE (1985) Pheochromocytoma. Clin Endocrinol Metab 14: 203
Lewis PD (1971) A cytophotometric study of benign and malignant pheochromocytomas. Virchows Arch 9: 371
Medeiros LJ, Wolf BC, Balogh K et al. (1985) Adreanl pheochromocytoma a clinicopathologic review of 60 cases. Hum Pathol 16: 580
van Heerden JA, Sheps SG, Hamberger B et al. (1982) Pheochromocytoma: current status and changing trends. Surgery 91: 367
Bravo EL, Gifford RW Jr (1984) Pheochromocytoma diagnosis, localisation and management. N Engl J Med 311: 1298–1303
Modlin IM, Farndon JR, Shepherd A et al. (1979) Pheochromocytoma in 72 patients: clinial and diagnostic features, treatment and long term results. Br J Surg 66: 456–465
Sheedy PE II, Hattery RR, Stephens DH et al. (1983) Computed tomography of the adrenal gland. In: Hagga JR, Alfidi FJ (eds) Computed Tomography of the whole Body, Vol 2 St Louis C.V. Mosby 681–697
Reinig JW, Doppman JL (1986) Magnetic resonance imaging of the adrenal. Radiologe 26: 186
Shapiro B, Copp JE, Sisson JC et al. (1985) Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26: 576
Ross EJ, Richard BNC, Kaufmann L et al. (1969) Preoperative and operative management of patients with pheochromocytoma: Anesth Ana1g Reanimatol 59: 154–162
Shapiro B, Sisson JC, Wieland DM (1991) Radiopharmaceutical therapy of malignant pheochromocytoma with I131 metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 35: 269–276
Lumbroso J, Schlumberger M, Tenenbaum F et al. (1991) I131-metaiodobenzylguanidine therapy in 10 patients with malignant pheochromocytoma. J Nucl Biol Med 35: 288–291
Krempf F, Lumbroso J, Mornex R et al. (1991) Treatment of malignant pheochromocytoma with I131 metaidobenzylguanidine: a French multicenter study. J Nucl Biol Med 35: 284–287
Troncone L, Ruffini V, Daidone MS et al. (1991) I131-metaidobenzylguanidine treatment of malignant pheochromocytoma: experience of the Roma group
Keiser H, Goldstein DS, Wade JL et al. (1985) Treatment of malignant pheochromocytoma with combination chemotherapy: Hypertension I-18–24
Averbuch SD, Steakley CR, Young RC et al. (1988) Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, Vincristine and Dacarbazine. Ann Int Med 109: 267–273
Feldman JM (1983) Treatment of metastatic pheochromocytoma with streptozocin. Arch Int Med 143: 1799–1800
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Eriksson, B., Öberg, K. (1995). Nebennierentumoren. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10494-1_29
Download citation
DOI: https://doi.org/10.1007/978-3-662-10494-1_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58586-2
Online ISBN: 978-3-662-10494-1
eBook Packages: Springer Book Archive